0001485003-21-000126.txt : 20210603
0001485003-21-000126.hdr.sgml : 20210603
20210603184529
ACCESSION NUMBER: 0001485003-21-000126
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210601
FILED AS OF DATE: 20210603
DATE AS OF CHANGE: 20210603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Drake Patricia M.
CENTRAL INDEX KEY: 0001865279
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 21994129
MAIL ADDRESS:
STREET 1: 245 FIRST STREET, SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_162276028625368.xml
FORM 4
X0306
4
2021-06-01
0
0001485003
Sesen Bio, Inc.
SESN
0001865279
Drake Patricia M.
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
0
1
0
0
Chief Commercial Officer
Employee Stock Option (Right to Buy)
3.87
2021-06-01
4
A
0
1000000
0
A
2031-06-01
Common Stock
1000000.0
1000000
D
25% of the shares subject to such option shall vest on the first anniversary of the date of grant of the option and an additional 6.25% of the shares underlying the option shall vest at the end of each successive three-month period thereafter until the fourth anniversary of the date of grant of the option. Based on market analysis by Radford of public, pre-commercial biopharmaceutical companies, the compensation committee of Sesen Bio, Inc ("the Company"), recommended to the Company's board of directors, and the board of directors approved, the grant to the reporting person.
/s/ Mark R. Sullivan, as attorney-in-fact
2021-06-02